Musculoskeletal Tissue
Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Public Assessment Report
(PAR)
22-11-2017
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
Bone, Quantity: 30 % w/w
Available from:
Johnson & Johnson Medical Pty Ltd t/a DePuy Synthes
INN (International Name):
DBX Putty
Pharmaceutical form:
Paste
Composition:
Excipient Ingredients: hyaluronic acid
Administration route:
Implant
Class:
Class 3
Therapeutic area:
Musculoskeletal Tissue
Therapeutic indications:
DBX is indicated for treatment of surgically created osseous defects or osseous defects created from traumatic injury. DBX can be used as an extender in orthopaedic spine and trauma use with autograft, allograft and bone marrow aspirate.
Authorization status:
A
Authorization date:
2013-06-26
